日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FDA Approval Summary: Niraparib plus Abiraterone Acetate Fixed-Dose Combination for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

FDA批准摘要:尼拉帕尼联合醋酸阿比特龙固定剂量组合用于治疗BRCA突变转移性去势抵抗性前列腺癌

Maguire, William F; Chi, Dow-Chung; Agrawal, Sundeep; Joeng, Hee-Koung; Kim-McOlash, Sarah; Manheng, Wimolnut; Bulatao, Ilynn; Sanchez-Solana, Beatriz; Pathak, Anand; Lee, Alice; Han, Yu; Ricks, Tiffany K; Hamed, Salaheldin S; Fiero, Mallorie H; Pierce, William F; Kalavar, Shyam; Ghosh, Soma; Leighton, John K; Tang, Shenghui; Amiri-Kordestani, Laleh; Kluetz, Paul G; Suzman, Daniel L

FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma

FDA批准摘要:托沃拉非尼用于治疗复发或难治性BRAF突变型儿童低级别胶质瘤

Singh, Sonia; Bradford, Diana; Chatterjee, Somak; Li, Xiaoxue; Aungst, Stephanie L; Skinner, Amy M; Miller, Claudia P; Kim-McOlash, Sarah; Fourie Zirkelbach, Jeanne; Xiong, Ye; Bi, Youwei; Wang, Ying-Hong; Yang, Yuching; Sun, Jielin; Kraft, Jeffrey; Charlab, Rosane; Shord, Stacy S; Tang, Shenghui; Scepura, Barbara; Bulatao, Ilynn; Udoka, Opeyemi; Saber, Haleh; Rahman, Nam Atiqur; Pazdur, Richard; Singh, Harpreet; Donoghue, Martha; Drezner, Nicole

Novel Interventions to Improve Adherence to Guideline-Directed Medical Therapy in Claudicants

提高间歇性跛行患者对指南指导药物治疗依从性的新型干预措施

Shi, Richard; Bulatao, Nicholas; Tanious, Adam

Cardiac Adverse Events in Patients Receiving Immune Checkpoint Inhibitors in the Adjuvant Setting: An FDA Pooled Analysis

接受免疫检查点抑制剂辅助治疗的患者发生心脏不良事件:FDA汇总分析

Dilawari, Asma; Krantz, Mori J; Bulatao, Ilynn; Joeng, Hee-Koung; Neilson, Marc; Wedam, Suparna; Gao, Xin; Fiero, Mallorie H; Nair, Abhilasha; Theoret, Marc; Amiri-Kordestani, Laleh

Redefining Counterfeit Medicines and Updating the Legal Framework to Address Falsified Medicines: A Qualitative Policy Review

重新定义假药并更新法律框架以应对假药问题:一项定性政策评估

Peña, Imelda G; Robles, Yolanda R; Salenga, Roderick L; Loquias, Monet M; Capule, Francis R; Bulatao, Bryan Paul I; Casauay, Jean Flor C

US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, ESR1-Mutated Advanced or Metastatic Breast Cancer

美国食品药品监督管理局批准摘要:Elacestrant 用于治疗雌激素受体阳性、人表皮生长因子受体 2 阴性、ESR1 突变的晚期或转移性乳腺癌

Shah, Mirat; Lingam, Hima; Gao, Xin; Gittleman, Haley; Fiero, Mallorie H; Krol, Danielle; Biel, Nikolett; Ricks, Tiffany K; Fu, Wentao; Hamed, Salaheldin; Li, Fang; Sun, Jillian Jielin; Fan, Jianghong; Schuck, Robert; Grimstein, Manuela; Tang, Liuya; Kalavar, Shyam; Abukhdeir, Abdelrahmman; Pathak, Anand; Ghosh, Soma; Bulatao, Ilynn; Tilley, Amy; Pierce, William F; Mixter, Bronwyn D; Tang, Shenghui; Pazdur, Richard; Kluetz, Paul; Amiri-Kordestani, Laleh

Embryos assist morphogenesis of others through calcium and ATP signaling mechanisms in collective teratogen resistance

胚胎通过钙和ATP信号机制辅助其他胚胎的形态发生,从而实现集体抗致畸作用。

Tung, Angela; Sperry, Megan M; Clawson, Wesley; Pavuluri, Ananya; Bulatao, Sydney; Yue, Michelle; Flores, Ramses Martinez; Pai, Vaibhav P; McMillen, Patrick; Kuchling, Franz; Levin, Michael

Design and development of a magnetic field-enabled platform for delivering polymer-coated iron oxide nanoparticles to breast cancer cells

设计和开发磁场驱动平台,用于将聚合物包覆的氧化铁纳米粒子递送至乳腺癌细胞

Bryan Paul Bulatao, Nonthaneth Nalinratana, Pongsakorn Jantaratana, Opa Vajragupta, Pornchai Rojsitthisak, Pranee Rojsitthisak

Folic Acid-Grafted Chitosan-Alginate Nanocapsules as Effective Targeted Nanocarriers for Delivery of Turmeric Oil for Breast Cancer Therapy.

叶酸接枝壳聚糖-海藻酸盐纳米胶囊作为有效的靶向纳米载体,用于递送姜黄油治疗乳腺癌

San Htet Htet Moe, Alcantara Khent Primo, Bulatao Bryan Paul I, Sorasitthiyanukarn Feuangthit Niyamissara, Nalinratana Nonthaneth, Suksamrarn Apichart, Vajragupta Opa, Rojsitthisak Pranee, Rojsitthisak Pornchai

Fabrication of Curcumin Diethyl γ-Aminobutyrate-Loaded Chitosan-Coated Magnetic Nanocarriers for Improvement of Cytotoxicity against Breast Cancer Cells

制备姜黄素二乙酯γ-氨基丁酸酯负载的壳聚糖包覆磁性纳米载体以提高其对乳腺癌细胞的细胞毒性

Hansapaiboon, Supakarn; Bulatao, Bryan Paul; Sorasitthiyanukarn, Feuangthit Niyamissara; Jantaratana, Pongsakorn; Nalinratana, Nonthaneth; Vajragupta, Opa; Rojsitthisak, Pranee; Rojsitthisak, Pornchai